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Abstract
Despite advances in HIV prevention and care, African American and Latino Americans remain at
much higher risk of acquiring HIV, are more likely to be unaware of their HIV-positive status, are
less likely to be linked to and retained in care, or to have suppressed viral load than are Whites.
The first National HIV/AIDS Strategy (NHAS) has reducing these disparities as one of its three
goals by encouraging the implementation of combination high impact HIV intervention strategies.
Federal agencies have expanded their collaborations in order to decrease HIV-related disparities
by: better implementation of data-driven decision-making; integration and consolidation of the
continuum of HIV care; and the reorganization of relationships among public health agencies,
researchers, community-based organizations (CBO), and HIV advocates. Combination Prevention,
the integration of evidence-based and impactful behavioral, biomedical, and structural intervention
strategies to reduce HIV incidence, provides the tools to address the HIV epidemic. Unfortunately,
health disparities exist at every step along the HIV testing-to-care continuum. This provides an
opportunity and a challenge to everyone involved in HIV prevention and care to understand and
address health disparities as integral to ending the HIV epidemic in the U.S. To further reduce
health disparities, successful implementation of NHAS and combination prevention strategies will
require multi-disciplinary teams, including psychologists with diverse cultural backgrounds and
experiences, to successfully engage groups at highest risk for HIV and those already HIV-infected.
In order to utilize the comprehensive care continuum, psychologists and behavioral scientists have
a role to play in re-conceptualizing the continuum of care, conducting research to address health
disparities, and creating community mobilization strategies.
Introduction
Ethnic and racial health disparities have existed from the beginning of the HIV epidemic
(Hall, Byers, Ling, & Espinoza, 2007). Higher HIV prevalence and incidence are observed
among African Americans and Latino Americans relative to their representation in the
population (Centers for Disease Control and Prevention [CDC], 2012b). Disparities have
also been documented in important HIV-related care parameters, such as linkage to and
retention in care and viral suppression (CDC, 2013). African Americans and Latino
Americans are identified later in their course of HIV disease and are less likely to be
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engaged in medical care than are White persons living with HIV (PLWH) (Andersen et al.,
2000). Even after anti-retroviral therapies (ARVs) were introduced in the mid-1990s, and
HIV-related deaths declined dramatically among all racial and ethnic groups, rates of decline
were least among African Americans and Latino Americans (Hall et al, 2007; Levine et al.,
2010). The time is ripe for psychologists to help the nation address these disparities, as the
first National HIV Prevention Strategy (NHAS) outlines three primary goals, one of which
is to reduce HIV-related health disparities (White House Office of National AIDS Policy,
2010).
Despite the statistics that reflect troubling health disparities, there is global recognition that
the broad range of available prevention tools can be used to create a generation free of
AIDS. In part, this optimism is due to a series of biomedical breakthroughs, particularly the
ability of ARVs to reduce HIV transmission (Cohen, 2011; Cohen et al., 2012) and
acquisition (Grant et al., 2010), and to extend and increase the quality of life of PLWH
(Department of Health and Human Services, 2012). There is also increasing recognition
about the importance of not only identifying people with unrecognized HIV infection, but
also linking and retaining HIV-positive persons in care to achieve the maximum viral
suppression at both the individual and community levels. While the prevalence of HIV
testing and linkage to care is relatively high, the proportion of HIV-positive persons who
remain in care, achieve viral suppression, and receive prevention counseling is low (CDC,
2011c). The broad array of available prevention tools has resulted in efforts to combine HIV
prevention interventions together in order to have the highest impact on the HIV epidemic
(White House Office of National AIDS Policy, 2010). Combination Prevention is defined as
the integration of behavioral, biomedical, and structural HIV intervention strategies (Kurth,
Celum, Baeten, Vermund, & Wasserheit, 2011), and because all combinations are not
equally efficacious, it is important to emphasize the need for high-impact combinations if
we are to stop the HIV epidemic (CDC, 2011b). Scaling-up high-impact combination
prevention holds the promise to significantly impact the HIV epidemic and represents the
best strategy to significantly reduce health disparities.
Whereas having the tools and policies to address the HIV epidemic presents opportunities,
the persistence of racial and ethnic health disparities presents a challenge to everyone
involved in HIV prevention and care. These opportunities and challenges are most apparent
when examining the health disparities that exist at each step in the HIV testing-to-care
continuum (Gardner, McLee, Steiner, del Rio, & Burman, 2010; Valdesseri, 2012). Health
disparities are evident in awareness of HIV infection, linkage to HIV care for those who test
positive, retention in HIV care, and adherence to ARV treatment to achieve viral
suppression. Psychologists have unique expertise in understanding how social systems
interact with individual behavior to impact health, an expertise that has been critical in
creating theory-driven and evidence-based strategies to decrease health disparities.
Thomas and colleagues (2011) have described three phases of research on health disparities:
first, documenting the existence of disparities (well-documented for HIV); second,
identifying causes, including social determinants of disparities, as well as disease-specific
causes (again, well-documented for HIV); and third, creating programs to reduce disparities,
similar to the existing behavioral interventions available from the CDC (Effective
Interventions, 2012; CDC, 2008). A fourth phase of research on health disparities is
proposed in which the complex structural relationships between factors such as poverty and
racism are related to health disparities (Thomas, Quinn, Butler, Fryer, & Garza, 2011).
Multi-level, comprehensive interventions which explore more than one HIV-associated
outcome, especially those drivers of HIV-associated racial and ethnic health disparities,
could be responsive to the new, broader paradigm to reduce health disparities. Psychologists
and behavioral scientists who aim to participate in the fourth generation of research can
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work to minimize the ways in which their research practices mirror existing social structures
that contribute to health disparities. Psychologists also design and conduct research to
directly address those social determinants and structural factors that allow health disparities
to persist.
This article will briefly describe the NHAS as a policy roadmap to addressing health
disparities in HIV, describe the opportunities afforded by high-impact combination
prevention, and discuss the challenges presented by the health disparities across the HIV
testing-to-care continuum. The opportunities for psychologists and behavioral scientists to
influence how HIV prevention and care is conceptualized, researched, and implemented will
be highlighted throughout.
National HIV/AIDS Prevention Strategy (NHAS)
At a structural level, the NHAS represents a visionary document that aims to produce
significant programmatic and policy changes to address the HIV epidemic and HIV health
disparities in the United Sates. NHAS aims to achieve three main goals by 2015: 1) reduce
the number of people who become infected with HIV; 2) increase access to care and optimal
health outcomes for PLWH; and 3) reduce HIV-related health disparities. The NHAS
recognizes that there is no single solution to addressing HIV in the United States,
emphasizing the importance of implementing a combination of approaches to prevention. A
fourth goal of NHAS, achieving a more coordinated response to the HIV epidemic,
encourages collaborations at the federal level and between federal agencies and state,
territorial, local and tribal governments, as well as the development of the mechanisms to
monitor progress toward the first three goals (White House Office of National AIDS Policy,
2010).
In response to the NHAS goals, the CDC initiated a demonstration project called the
Enhanced Comprehensive HIV Prevention Planning (ECHPP) project in the 12 Metropolitan
Service Areas (MSAs) with the most cases of AIDS (CDC, 2011a). The 12 ECHPP MSAs
represented 44% of cases in the United States at that time (CDC, 2011a). ECHPP aimed to
improve program planning in each MSA by utilizing a mix of interventions to maximize the
impact of HIV combination prevention locally. The ECHPP project tried to improve upon
existing practices by asking health departments to: 1) examine all local HIV prevention,
care, and treatment resources, regardless of source (federal, state, private, foundations); 2)
direct resources to achieve maximum impact on HIV incidence; 3) use a core set of
behavioral, biomedical, and structural interventions implemented in combination, targeted,
and scaled to maximize appropriate coverage and impact; and 4) increase data-driven
decision making by attempting to incorporate local epidemiologic, cost-effectiveness and
efficacy data (CDC, 2011a). To support NHAS and cross-agency collaboration, the National
Institutes of Health funded supplements for two different research programs to conduct
small pilot studies in most of the ECHPP cities. (District of Columbia Developmental Center
for AIDS Research, 2012). These initiatives are ongoing, and in addition to their future
outcomes, they provide a structure for continued collaboration across agencies. In addition,
CDC’s core funding for state health departments across the nation also incorporated the
principles of high impact prevention (CDC, 2011d)
In late 2012, CDC funded a second generation demonstration project in eight states called
Care and Prevention in the United States (CAPUS) (CDC, 2012a). The three goals of this
program, which is focused on racial and ethnic minorities, are to 1) increase identification of
unknown HIV-positive persons, 2) increase linkage, retention, and re-engagement in care,
and 3) address health disparities that directly and proximally affect these first two goals.
Unique aspects of this program are the direct focus on health disparities, a requirement that
25% of the funding be dedicated to community-based organizations, and the involvement of
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multiple federal agencies in the planning and management of the program (including the
Department of Health and Human Services [HHS], the Health Resources Services
Administration [HRSA], and the Substance Abuse and Mental Health Services
Administration [SAMHSA]) (CDC, 2012a).
The NHAS implementation has encouraged closer working relationships among public
health departments, psychologists, AIDS service organizations, medical clinics, academic
researchers and advocates. In many cases, public health departments are leading the agenda-
setting for the types of research, policy and program questions that are important to their
jurisdictions and, as a result, research projects are conceptualized and prioritized based on
their salience to the local epidemic. Through capacity-building partnerships, academic
researchers support the public health departments with the goal of creating stronger
bidirectional relationships. This reorganization is a fundamental shift in ongoing priorities
for setting research agendas at the local level from academic institutions to public health
authorities. As highlighted by CDC funding of state health departments nationwide, as well
as the ECHPP and CAPUS demonstration projects, each community, region, and state must
base their planning and implementation of combination prevention strategies tailored to their
local epidemic. Communities will need to shape their implementation policies based on the
size and demographics of their local HIV epidemic, as well as leverage improvements in
access to testing, linkage to care, and maintenance in care at each point on the treatment
cascade.
Addressing health disparities across the HIV testing-to-care continuum
The continuum from HIV testing, to long-term adherence to care comprises the steps
necessary to intervene upon and measure progress towards the NHAS goals. The HIV
testing-to-care continuum presents a series of opportunities for implementation of high
impact combination prevention interventions to reduce both HIV and associated health
disparities by:
1. identifying HIV-positive persons as soon as possible after HIV infection;
2. linking them to and retaining them in care;
3. ensuring access to and utilization of ARVs for all HIV-positive persons and
4. sustaining them in health care lifelong to realize the individual and community
benefits of treatment.
Health disparities exist at every step along the continuum with gaps in each step contributing
in an overlapping and cumulative fashion to perpetuate racial and ethnic health disparities
(CDC, 2010a). In addition, ARV-based interventions can be implemented as part of the
combination of interventions as they have demonstrated significant impact on HIV
incidence, in addition to their well-known health benefits when administered for the
purposes of HIV treatment.
Unfortunately, challenges remain in regards to ensuring adequate access and utilization
across all steps of the HIV testing-to-care continuum, so the benefits can be realized across
all groups. Psychologists and behavioral scientists have a role to play in designing
interventions, and conducting their research in such a way as to assist in addressing the
health disparities in HIV. Interventions are needed, to be included as part of high impact
combination prevention, that attend to the racial and ethnic disparities at every step along the
continuum.
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HIV testing: increasing awareness of HIV status and targeting PrEP and n-PEP for
prevention
Scaling-up of HIV testing is a critical component of combination prevention, due to the high
transmission potential for those who are unaware of their HIV status. Currently, just fewer
than 20% of people living with HIV in the United States do not know their HIV status
(CDC, 2011c). Thus, HIV testing serves as an important tool for the purposes of ensuring
that individuals know their HIV status and, for those who test HIV-positive, can be rapidly
linked to HIV care. However, racial and ethnic disparities exist within the group of people
unaware of their HIV status. White, non-Latino Americans have the lowest percentage of
undiagnosed infections compared with Latino Americans and African Americans (CDC,
2010a). Ensuring that HIV testing is routine at locations that are more likely to be accessed
by African Americans and Latino Americans, such as emergency rooms, is important
because these sites are least likely to routinely test for HIV (Jha, Li, Orav, & Epstein, 2005;
Hsieh, Rothman, Newman-Toker, & Kelen, 2008; Hsieh, Wilbur, & Rothman, (2012). The
use of conventional lab-based HIV screening, batched hourly, has been shown to
dramatically increase routine HIV screening in a high-volume emergency room (Hoxhaj et
al., 2011), and this method holds promise for expanding HIV testing to other high-volume
settings that serve racially and ethnically diverse patients.
Community mobilization is one approach that has been used to address health disparities
across a variety of health conditions and is also a common approach to increase the uptake
of HIV testing. Two highly visible, recent efforts underway in Washington, D.C., and the
Bronx, New York (McNeil 2012; New York City Department of Health and Mental
Hygeine, 2011) are aimed at engaging and mobilizing the African American and Latino
American communities, particularly around HIV testing. For example, in 2006, multiple
agencies, let by the public health department, formed a coalition to stop transmission in
Washington, D.C. and a multi-prong approach, including the widespread provision of
insurance, was adopted with routine, rapid HIV testing implemented in all health care
settings. The rates of HIV testing increased threefold within the first year, and 24% of the
population was tested within one year (CDC, 2010b). Increases were also observed in the
number of individuals receiving CD4 cell counts within three months of an HIV diagnosis.
These efforts demonstrate the power of effective community mobilization, and structural
level changes which serve as a platform upon which to build implementation efforts.
Historically, clinic- and community-based venues have been the primary locations for HIV
testing; however, the recent FDA approval of the first oral-fluid, rapid, consumer-controlled,
home-based HIV test provides an alternative to previous approaches. It is too early to know
if this new option for HIV testing will have any impact on racial and ethnic disparities in
knowledge of HIV serostatus. It is possible that disparities seen in awareness of HIV status
could be lessened by the availability of a home-testing kit for HIV. Given that mistrust in the
medical system has been documented among African Americans and Latino Americans, this
testing option may offer an alternative that may substantially improve HIV testing rates
among those communities (Bogart et al., 2010, 2011). However, the costs of the test kit, and
ensuring subsequent linkage to care for those who test HIV positive, are among the
challenges. Thus, individuals who test HIV positive at home face the challenge of
interacting with a medical system that they may not trust, potentially resulting in low rates
of linkage to HIV care.
Another tool in the combination prevention toolbox is pre-exposure prophylaxis (PrEP),
which is the use of ARVs for HIV prevention among HIV-negative individuals who take
drugs in advance of potential exposure (Grant et al., 2010). This adds to the ARV-based
prevention options for people who are HIV-negative joining non-occupational post-exposure
prophylaxis (n-PEP), which is when ARVs are taken soon after a suspected exposure to HIV
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(Schechter et al., 2004). Again, it is too early to tell if PrEP will have an impact on racial
and ethnic health disparities, but the data on the n-PEP uptake suggest that disparities may
be seen. Outside of occupationally related PEP, n-PEP is most typically used by gay and
bisexual men and other men-who-have-sex-with-men [MSM], the group with the highest
prevalence of HIV (CDC, 2005; Shoptaw et al, 2008). There are currently many community
efforts to increase uptake of n-PEP among African American and Latino American
communities (Gay, Kashuba, & Cohen, 2009; Schechter et al., 2004). However,
participation by racial/ethnic minority MSM (24%–49%) remains lower than participation
by Caucasian MSM (46%–76%) (Krakower et al., 2012; Mayer, Mimiaga, Gelman, &
Grasso, 2012; Mimiaga, Case, Johnson, Safren, & Mayer, 2009; Roland et al., 2011; Sayles
et al., 2011).
To gather early data on PrEP knowledge, prior to the FDA approval, a series of studies
examined the anticipated barriers and attitudes towards the utilization of PrEP by MSM,
including African Americans and Latino Americans (Al Tayyib & Trun, 2011; Brooks et al.,
2009; Eisingerich, 2012; Krakower et al., 2012; Liu et al, 2008; Mimiaga et al., 2009).
Overall, knowledge of PrEP is low and willingness to utilize PrEP is dependent on a range
of factors including stigma, perceived personal risk of HIV infection, ARV side effects, and
accessibility and sustainability of access to ARV. As PrEP demonstration studies are
continuing, close observation of potential racial and ethnic disparities should be monitored
and addressed.
Psychologists and behavioral scientists have a role to play in creating effective community
mobilization strategies, understanding the roll-out of new tools such as home-testing, and
most importantly, documenting their effectiveness in addressing health disparities.
Consistent with the NHAS aims, research is needed to demonstrate that interventions and
strategies to increase the number of individual who are aware of their HIV status are both
effective and cost-effective. Thus, part of the role of research psychologists and behavioral
scientists, is to continue to systematically document linkages between the social and
individual factors, and the health outcomes disparities. When disparities in health outcomes
cannot be explained by lack of access or utilization of a given HIV prevention modality,
theories of health disparities (e.g., Thomas et al., 2011) suggest looking to underlying, and
often more distal, social and structural factors.
Linkage to HIV Care
Timely linkage to HIV care following a seropositive HIV test is critical, made even more so
by the data on the individual and prevention benefits of ARV treatment (Cohen, 2011).
Rates of linkage to HIV care vary widely across jurisdictions, but are generally suboptimal
(CDC, 2011c). For example, in Los Angeles, 37% of PLWH do not access care in the first
year following HIV diagnoses (Leibowitz, Mendes, & Desmond, 2011). In the Kaiser
Permanente HIV Cohort Study (2012), African Americans and Latino Americans presented
with lower CD4 counts (later in diagnosis) than Whites, suggesting late diagnosis, delayed
linkage, or both. Recent CDC data for 12 states and 2 MSAs indicated lower linkage to care
among African Americans (75%) compared to whites (83.1%) and Latino Americans
(82.7%) and substantial variation between jurisdictions (CDC, 2013).
Multiple strategies, employing principles from social and behavioral science, are being
explored to make linkage to care an immediate step after testing (Kalichman et al., 2011).
Some examples include, peer-based strategies to help individuals navigate the health care
system and address barriers to access and utilization, and contingency management
approaches which incentivize timely linkage to care (Prendergast, Podus, Finney,
Greenwell, Roll, 2006; Reback et al., 2010). However, few approaches are aimed at
addressing the social determinants that underlie health disparities. Though not specific to
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HIV, a report by the Institute of Medicine (IOM) outlines specific recommendations
regarding changes to the health care system that are needed to eliminate racial and ethnic
health disparities (Smedley, Stitch, & Nelson, 2003). Many of the recommendations from
the IOM report are applicable to the disparities in HIV care. For example, the report calls for
a greater understanding, through research, of the role that beliefs and attitudes on the part of
patients and providers play in their behavior. PrEP, n-PEP, home based testing, and
sustained linkage to care will vary substantially based on beliefs of PLWH, especially
African Americans and Latino Americans. Psychologists and behavioral scientists have been
influential in developing theories of behavior change that include such psychosocial factors
as attitudes and beliefs. These theoretical models could be integrated with theories of health
disparities to include the social (e.g., racism, stigma) and structural (e.g. poverty) factors that
may work together to drive racial and ethnic health disparities.
Retention in HIV Care and Adherence to ARV Treatment
Once a PLWH is linked to HIV care, the personal and prevention benefits of treatment are
only seen among those individuals who stay in care and maintain a suppressed viral load
(Das et al, 2010). Retention in care has been defined in multiple ways using different
parameters such as clinic attendance or laboratory monitoring. Despite the challenges of
determining a singular definition of retention in HIV care, all available data indicate that
rates of retention in care in the U.S. are suboptimal (CDC, 2013). In addition, significant
racial and ethnic disparities exist with recent CDC data for indicating that retention in care
was lower for African Americans (37.7%) than Whites (47.6%) and Latino Americans
(40.7%) with substantial variation between jurisdictions (CDC, 2013). Poor retention in care
limits the accessibility of ARV treatment for individual and prevention benefits, contributes
to worse HIV-related health outcomes, decreases the opportunity to detect non-HIV-related
health conditions that can be identified during the course of routine HIV care, and limits
exposure to HIV prevention services.
Sustained viral suppression has become a cornerstone to prevention with PLWH because of
the evidence that treatment can reduce transmission by up to 96% (Cohen & Gay, 2010).
And apart from a select group of individuals, most PLWH require sustained adherence to
ARV treatment to achieve viral suppression. In addition there is growing evidence of the
individual benefits of starting on ARV treatment at higher CD4 counts, in an earlier stage of
the disease, than was previously recommended (Department of Health and Human Services,
2012). Again, the data suggest that improvements are needed in terms of the percentage of
PLWH in the U.S. who are living with their virus fully suppressed. Nationally, viral
suppression is only seen among 25% of PLWH (Medicaid Monitoring Data, 2011) with
African Americans and Latino Americans engaged in HIV care exhibiting the lowest rates.
Recent CDC data for 12 states and two MSAs showed that viral suppression was lowest
among African Americans diagnosed with HIV (61.3%) with the highest rates among
Whites (78.3%). Suppression among Latino Americans was in between the other two groups
(71.4%) (CDC, 2013). Some potential contributing factors to this disparity can be found in
factors that influence access to ARV medications. For example, prescriptions for ARV
medications are least likely to be consistently accessible for minorities (Kalichman, Catz, &
Ramachandran, 1999). In May, 2012, about 2700 PLWH in ten states have waiting lists for
receipt of ARV medications (Childress, 2012; Kaiser Family Foundation, 2012). The data on
waitlists are not broken down by race or ethnicity. However, the presence of wait-lists, that
include individuals who qualify for ARV medication, works against the HIV health care and
prevention goals of NHAS, CDC, and local health jurisdictions.
Among those individuals linked to care and on ARV medication, there is some evidence that
adherence may vary by race/ethnicity with African American and Latino American patients
demonstrating lower levels of adherence to ARVs (Kaiser Permanente HIV Cohort Study,
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2012). There is substantial evidence that adherence is lower among populations with low
levels of education, health literacy, or income (Braverman & Dedier, 2009; Reback et al.,
2010; Sankar, Neufeld, Berry, & Luborsky, 2011; Weingarten et al., 2002). Poverty,
substance use, high levels of homophobia, and a long tradition of barriers to accessing and
receiving high quality health care have been associated with HIV rates among marginalized
populations (Groh et al., 2011; Kalichman et al., 1999; Mannheimer et al., 2005). For
example, persons without transportation, who speak a different language than their provider,
or with a different set of norms regarding interaction, are far less likely to be adherent to
medical regimens (Kalichman et al., 1999). Thus, even if they are able to adhere to
medications, some disproportionately affected groups may have difficulty remaining in HIV
or primary medical care. That said, it is important to note that racial and ethnic differences
have not been shown in the efficacy of adherence support interventions (Simoni, Pearson,
Pantalone, Marks, & Crepaz, 2006). Also, the potency of ARV medication is sufficient to
eliminate racial and ethnic disparities in morbidity and mortality among those retained in
HIV care as demonstrated in one large urban clinic (Moore & Bartlett, 2011). Therefore,
ARV treatment and behavioral interventions provide effective tools that, if adequately
deployed, could reduce or eliminate some HIV related health disparities.
Public health specialists and health care providers are challenged in gaining trust, reaching,
and maintaining relationships with those most impacted by HIV (Mays, Cochrane, &
Zamudio, 2004). For example, trust is a key issue for African Americans to be effectively
engaged in HIV prevention (Bogart et al., 2010). One study found half of the African
American study participants believed HIV was man-made and the government was using
African Americans as guinea pigs, withholding cures for HIV from the public (Bogart et al.,
2011). These data suggest that conspiracy beliefs remain real for some African Americans
(Bogart et al., 2011). Psychologists and behavioral scientists may play an important role in
understanding and addressing the psychosocial factors such as stigma, racism, and medical
mistrust that have been associated with decreases in access and utilization of HIV prevention
and care.
Psychologists have unique expertise in understanding individual behavior and social systems
and how they impact health. Research conducted by psychologists has sought to increase the
uptake of HIV testing, facilitate immediate linkage to care, increase adherence to
medications, and enhance maintenance of medical care lifelong. Behavioral and system level
changes are going to be needed in the organization of the continuum of HIV care to integrate
combination prevention approaches. In addition, culturally competent psychologists are
needed to enhance cultural sensitivity at the individual and systems level to the cultural
norms, values, and beliefs of key populations.
Challenge for psychologists
National policies regarding HIV have been restructured with the NHAS and high-impact
combination prevention offering an array of tools that have the potential to dramatically
impact the HIV epidemic. Health disparities exist across the HIV testing-to-care continuum,
but the continuum presents the framework to examine the opportunities and challenges at
each step with regards to addressing racial and ethnic health disparities. The research
conducted by psychologists and behavioral scientists will be critical to informing the new
generation of combination prevention interventions, as well as their implementation, to
address health disparities. The creation of novel, scalable interventions that can eliminate
disparities along the HIV testing-to-care continuum and help to transform medical care to an
inviting, non-stigmatizing environment that successfully engages ethnic minority persons at
HIV risk or infected is a significant, but answerable challenge.
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Psychologists and behavioral scientists cannot address the pervasive health disparities alone.
Community engagement is critical to achieving the goals of NHAS, realizing the benefits of
the combination prevention tools and eliminating HIV infection. AIDS Service
Organizations, other NGOs, and advocates provide access to, deep knowledge of, and
sustained relationships over time with affected populations. Only sustained engagement and
structural supports at the local level will enhance utilization of HIV services by underserved
ethnic minority young people and adults (Phytel, 2012). Integrating the community
knowledge and expertise with that of the health care system is a formidable challenge made
even more urgent by the benefits of ARV medications for prevention goals. Communities
planning to implement ARV-based combination prevention will need procedures for
ensuring access (e.g., transportation, medical packaging, community health workers to
support adherence) combined with adequate public health education and engagement
(Denning & DiNenno, 2010; Kaiser Permanente HIV Cohort Study, 2012). Capacity
building efforts are needed that enhance, in an integrated way, the community, public health,
and medical expertise needed to successfully deliver combination prevention to the public.
Psychologists have been pioneers in the area of patient engagement (Joe, Simpson, &
Broome, 1999; Horstmann, Brown, Islam, Buck, & Agins, 2010). Though, not the focus of
this article, there is ample evidence of the role of mental health problems in HIV prevention
and care. In particular, mental health problems and disorders are consistently associated with
high risk of HIV, low adherence, and lack of maintenance in care (Heckman et al.,1998;
Clements-Nolle, Marks, Guzman, & Katz, 2001). Therapeutic approaches used by
psychologists, such as cognitive-behavioral approaches to improve mental health and health
behaviors, are an important component of HIV prevention and care. However, the
integration of mental health care with HIV prevention in care should be careful to not
exacerbate the factors that underlie the health disparities in both conditions.
Paralleling the disparities in access and engagement of minorities in the system of HIV care,
disparities exist in the research workforce. The National Academy of Sciences has called for
substantial increases in the numbers of scientists from ethnic minority groups and
international settings (Committee on Underrepresented Groups and the Expansion of the
Science and Engineering Workforce Pipeline, 2011). A recent analysis of NIH-funded grants
found that African American were under-represented by 10% among those receiving
funding, after controlling for a large number of educational, publication, and personal
history factors (http://www.nih.gov/news/health/aug2011/od-18.htm). Integrating the
research teams with cultures that value and provide equal power to behavioral, basic, and
biomedical expertise is likely to be as challenging as creating and broadly implementing
combination prevention strategies. The racial and ethnic disparities that exist in the scientific
workforce will pose a challenge to fully implementing combination prevention and realizing
reductions in HIV related health disparities.
In the long battle to eliminate health disparities, new tools are now available to eliminate
HIV-related disparities. By combining the exciting new biomedical discoveries with well-
established and emerging behavioral approaches, combination prevention today offers the
greatest hope for stopping HIV and eliminating disparities for the next generation. We
cannot achieve this goal without fundamentally transforming the policy structures,
theoretical models of implementation science, and our workforce. The NHAS and scientific
advances have provided the structural shifts in policy and the prevention and treatment tools
that could eliminate health disparities. Now our science, priorities, and workplace norms
must shift to embrace these changes.
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